ClearPoint Neuro Inc vs iShares MSCI South Korea ETF — how do they compare? ClearPoint Neuro Inc trades at $14.6 (market cap $454.21M), while iShares MSCI South Korea ETF trades at $174.86. The key difference: iShares MSCI South Korea ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | EWY | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $29.60 | $219.20 |
52-Week Low | $8.66 | $71.22 |
Enterprise Value | $488.79M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWY, the iShares MSCI South Korea ETF, trades at $174.49, up 6.97% in 24 hours, with a neutral technical signal overall. Recent news highlights South Korea's semiconductor sector volatility and government support initiatives, including a $3.52 billion fund for chip materials. The ETF's performance is tied to heavyweights like Samsung and SK Hynix, which have faced sharp declines amid AI-driven market swings.
Outlook remains cautious due to sector concentration risks and foreign capital outflows, but long-term potential exists if semiconductor demand stabilizes. Investors face volatility from leveraged ETF speculation curbs and global tech sentiment shifts, requiring careful risk assessment amid mixed analyst views.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →